FDA's Expedited Access Pathway

Friday, July 31, 2015

Source: MD+DI

FDA has long combated stereotypes that its regulatory process is too slow, too cumbersome, and discourages medical innovation in the United States. While Congress has been focused on legislating away regulatory hurdles for devices and drugs with bills like the 21st Century Cures Act, the agency itself has taken a different tack.

View All News »